Quest Laboratories share news, announcements and annual reports
NSE: QUESTLABPharmaceuticals & Biotechnology
Quest Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2024 · Issue price ₹97
Last close ₹81.95down ₹2.05 (2.44%)
Share price at the NSE close on 27 Oct 2026. Previous close ₹84.00.
27 Oct: open ₹82.00, high ₹84.00, low ₹81.95
52-week range of traded prices to 27 Oct 2026
₹68.60Low, 21 Sep 2026₹152.60High, 30 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹134 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 93,60098.7% delivered
Quest Laboratories board meetings
18 filed, newest first.
Sep 2026
May 2026
26 May · Board meeting
Feb 2026
5 Feb · Board meeting
Nov 2025
13 Nov · Board meeting
Jul 2025
24 Jul · Board meeting
17 Jul · Board meeting
Board Meeting to be held on 24-Jul-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .
May 2025
28 May · Board meeting
23 May · Board meeting
Jan 2025
27 Jan · Board meeting
23 Jan · Board meeting
Nov 2024
14 Nov · Board meeting
Sep 2024
24 Sep · Board meeting
18 Sep · Board meeting
Jul 2024
1 Jul · Board meeting
May 2024
30 May · Board meeting
29 May · Board meeting